Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.
Topics on the show include
- the emergence of personalized medicine and breakthroughs in genomics
- advances in biopharmaceuticals
- age related diseases and aging in place
- using big data from wearables and sensors
- transparency in the medical marketplace
- challenges for connected health entrepreneurs
The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.
Focus on Social Determinants of Health Driving Access-Focused Solutions with John Schwartz HSBlox TRANSCRIPT
May 27, 2021
John Schwartz is Chief Revenue Officer at HSBlox and he strongly believes that care coordination is essential for all patients. The challenge is how can healthcare stakeholders improve the delivery of Social Determinants of Health (SDOH) to better serve vulnerable people. Aligning medical and social care needs is a…Read More
Focus on Social Determinants of Health Driving Access-Focused Solutions with John Schwartz HSBlox
May 27, 2021
John Schwartz is Chief Revenue Officer at HSBlox and he strongly believes that care coordination is essential for all patients. The challenge is how can healthcare stakeholders improve the delivery of Social Determinants of Health (SDOH) to better serve vulnerable people. Aligning medical and social care needs is a…Read More
Stimulating Invariant Natural Killer T-Cells to Boost Immune System in Fight Against Cancer with Dr. Ian Walters Portage Biotech TRANSCRIPT
May 25, 2021
Dr. Ian Walters is CEO of Portage Biotech is building a pipeline of novel immunotherapies for the treatment of cancer particularly for patients who do not respond to current therapies. The key is stimulating a type of immune cell called invariant natural killer T-cell which works with the adaptive immune system to…Read More
Stimulating Invariant Natural Killer T-Cells to Boost Immune System in Fight Against Cancer with Dr. Ian Walters Portage Biotech
May 25, 2021
Dr. Ian Walters is CEO of Portage Biotech is building a pipeline of novel immunotherapies for the treatment of cancer particularly for patients who do not respond to current therapies. The key is stimulating a type of immune cell called invariant natural killer T-cell which works with the adaptive immune system to…Read More
Focus on Protein Misfolding Leading to Drug Discovery Through Use of Supercomputer and Computational Chemistry with Manolo Bellotto Gain Therapeutics TRANSCRIPT
May 24, 2021
Manolo Bellotto, PhD is General Manager and President Gain Therapeutics and dedicated to redefining drug discovery through the use of supercomputers and proprietary algorithms to understand rare diseases and diseases where there is a high medical need related to protein misfolding. These indications include cancer,…Read More
Focus on Protein Misfolding Leading to Drug Discovery Through Use of Supercomputer and Computational Chemistry with Manolo Bellotto Gain Therapeutics
May 24, 2021
Manolo Bellotto, PhD is General Manager and President Gain Therapeutics and dedicated to redefining drug discovery through the use of supercomputers and proprietary algorithms to understand rare diseases and diseases where there is a high medical need related to protein misfolding. These indications include cancer,…Read More
Encouraging Lifestyle Changes Driving Significant Impact on Chronic Conditions with Tim Aumueller Avidon Health TRANSCRIPT
May 20, 2021
Tim Aumueller is the Co-CEO of Avidon Health and an expert on combining digital solutions and human coaching to help patients living with chronic diseases make lifestyle changes. While drugs will most likely always be part of a treatment plan, direct behavior change science is demonstrating the impact that healthy…Read More
Encouraging Lifestyle Changes Driving Significant Impact on Chronic Conditions with Tim Aumueller Avidon Health
May 20, 2021
Tim Aumueller is the Co-CEO of Avidon Health and an expert on combining digital solutions and human coaching to help patients living with chronic diseases make lifestyle changes. While drugs will most likely always be part of a treatment plan, direct behavior change science is demonstrating the impact that healthy…Read More
Dynamic Online Community and Resources for Patients with Rare Diseases with Dr. Kate Burke and Jed PatientsLikeMe TRANSCRIPT
May 18, 2021
Dr. Kate Burke is Senior Medical Advisor at PatientsLikeMe and Jed is a patient leader, advocate and patient with a range of conditions including ankylosing spondylitis (AS) and Lyme disease. They join me on the podcast to talk about the robust online community PatientsLikeMe and how it helps patients with rare diseases…Read More
Dynamic Online Community and Resources for Patients with Rare Diseases with Dr. Kate Burke and Jed PatientsLikeMe
May 18, 2021
Dr. Kate Burke is Senior Medical Advisor at PatientsLikeMe and Jed is a patient leader, advocate and patient with a range of conditions including ankylosing spondylitis (AS) and Lyme disease. They join me on the podcast to talk about the robust online community PatientsLikeMe and how it helps patients with rare diseases…Read More
Whole Body Scanning with Smartphone Camera Leads to Actionable Health Data with Vlado Bosanac Advanced Human Imaging TRANSCRIPT
May 17, 2021
Vlado Bosanac is Co-Founder of Advanced Human Imaging, a B2B tech company based in Australia. Using the camera on a smart phone, their applications can accurately track 12,000 data points across the human form to give a number of the markers that a doctor would look at. Giving this sort of information to individuals…Read More
Whole Body Scanning with Smartphone Camera Leads to Actionable Health Data with Vlado Bosanac Advanced Human Imaging
May 17, 2021
Vlado Bosanac is Co-Founder of Advanced Human Imaging, a B2B tech company based in Australia. Using the camera on a smart phone, their applications can accurately track 12,000 data points across the human form to give a number of the markers that a doctor would look at. Giving this sort of information to individuals…Read More
Addressing Social Determinants of Health in Marginalized and Unrepresented Communities with Kistein Monkhouse Patient Orator TRANSCRIPT
May 12, 2021
Kistein Monkhouse is the Founder of Patient Orator, a start-up that is focused on providing services to racial and ethnic minorities, lower-income communities, the elderly, LGBT communities and other people who are marginalized or underrepresented in receiving healthcare.
With a focus on systemic racism and implicit…Read More
Addressing Social Determinants of Health in Marginalized and Unrepresented Communities with Kistein Monkhouse Patient Orator
May 12, 2021
Kistein Monkhouse is the Founder of Patient Orator, a start-up that is focused on providing services to racial and ethnic minorities, lower-income communities, the elderly, LGBT communities and other people who are marginalized or underrepresented in receiving healthcare.
With a focus on systemic racism and implicit…Read More
Infusing Rhenium NanoLiposomes into Glioblastoma Showing High Efficacy Eradicating These Brain Tumors with Dr. Marc Hedrick PLUS Therapeutics TRANSCRIPT
May 10, 2021
Dr. Marc Hedrick, President and CEO, PLUS Therapeutics describes the challenges of fighting brain cancers like glioblastoma. The PLUS lead investigational asset Rhenium NanoLiposome (RNL) delivers radiation directly to the tumor using a method called Convection Enhanced Delivery. This approach allows the neurosurgeon…Read More
Infusing Rhenium NanoLiposomes into Glioblastoma Showing High Efficacy Eradicating These Brain Tumors with Dr. Marc Hedrick PLUS Therapeutics
May 10, 2021
Dr. Marc Hedrick, President and CEO, PLUS Therapeutics describes the challenges of fighting brain cancers like glioblastoma. The PLUS lead investigational asset Rhenium NanoLiposome (RNL) delivers radiation directly to the tumor using a method called Convection Enhanced Delivery. This approach allows the neurosurgeon…Read More
Treating Hypersensitivity Disorders by Focusing on Specific Sodium Channel with John Mulcahy SiteOne Therapeutics TRANSCRIPT
May 6, 2021
John Mulcahy PhD, President and CEO, SiteOne Therapeutics talks about broadening their pipeline from acute pain to hypersensitivity disorders like chronic cough and itching. Approach is to inhibit voltage-gated subtype sodium channel Nav1.7, a genetically validated target for pain. Stopping the pain signal in the…Read More
Treating Hypersensitivity Disorders by Focusing on Specific Sodium Channel with John Mulcahy SiteOne Therapeutics
May 6, 2021
John Mulcahy PhD, President and CEO, SiteOne Therapeutics talks about broadening their pipeline from acute pain to hypersensitivity disorders like chronic cough and itching. Approach is to inhibit voltage-gated subtype sodium channel Nav1.7, a genetically validated target for pain. Stopping the pain signal in the…Read More
Targeted Cancer Supportive Care Agent for Skin Toxicities with Michael McCullar and Hong Tang OnQuality Pharmaceuticals TRANSCRIPT
May 4, 2021
Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the pipeline they are building to address unmet clinical needs in the area of oncology supportive care for skin rashes such as Hand-Foot Skin Reaction and GI toxicities like chemotherapy-induced diarrhea. As…Read More
Targeted Cancer Supportive Care Agent for Skin Toxicities with Michael McCullar and Hong Tang OnQuality Pharmaceuticals
May 4, 2021
Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the pipeline they are building to address unmet clinical needs in the area of oncology supportive care for skin rashes such as Hand-Foot Skin Reaction and GI toxicities like chemotherapy-induced diarrhea. As…Read More
Liquid Biopsy Diagnostics Accurately Identify Pre-Cancer and Cancer Genes with Richard Brand DiaCarta TRANSCRIPT
May 3, 2021
Richard Brand, Chief Financial Officer, DiaCarta discusses precision molecular diagnostics that are being used for early detection of cancer. By using liquid biopsy technology, blood draw can be used for early detection and monitoring of people who have cancer and avoiding the need for a physical biopsy. Also a…Read More
Liquid Biopsy Diagnostics Accurately Identify Pre-Cancer and Cancer Genes with Richard Brand DiaCarta
May 3, 2021
Richard Brand, Chief Financial Officer, DiaCarta discusses precision molecular diagnostics that are being used for early detection of cancer. By using liquid biopsy technology, blood draw can be used for early detection and monitoring of people who have cancer and avoiding the need for a physical biopsy. Also a…Read More
Digital Health Platform Revolutionizing Management of Chronic Conditions with Rick Anderson DarioHealth TRANSCRIPT
Apr 29, 2021
Rick Anderson, President and General Manager of North America, DarioHealth discusses how the company is leading the way on digital therapeutics combining digital technologies, artificial intelligence, software, and human coaching to help people manage chronic conditions including hypertension, diabetes, obesity and back…Read More
Digital Health Platform Revolutionizing Management of Chronic Conditions with Rick Anderson DarioHealth
Apr 29, 2021
Rick Anderson, President and General Manager of North America, DarioHealth discusses how the company is leading the way on digital therapeutics combining digital technologies, artificial intelligence, software, and human coaching to help people manage chronic conditions including hypertension, diabetes, obesity and back…Read More
Democratizing Diagnostics of Infectious Diseases with Ron Chiarello Alveo Technologies TRANSCRIPT
Apr 28, 2021
Ron Chiarello PhD, Founder, CEO and Chairman of the Board, Alveo Technologies talks about the need for a low-cost, easy-to-use diagnostic platform to allow more people to detect and manage an infectious disease like COVID-19. Winning the XPRIZE Rapid COVID-19 Testing Competition has highlighted their be.well diagnostic…Read More
Democratizing Diagnostics of Infectious Diseases with Ron Chiarello Alveo Technologies
Apr 28, 2021
Ron Chiarello PhD, Founder, CEO and Chairman of the Board, Alveo Technologies talks about the need for a low-cost, easy-to-use diagnostic platform to allow more people to detect and manage an infectious disease like COVID-19. Winning the XPRIZE Rapid COVID-19 Testing Competition has highlighted their be.well diagnostic…Read More
Tackling Neuroinflammation to Reduce Pathological Brain Changes in Alzheimer’s Patients with Dr. R.J. Tesi INmune Bio TRANSCRIPT
Apr 26, 2021
Dr. R.J. Tesi, President and CEO, INmune Bio shines light on the complexity of the immune system by pointing out that while much work has been done on the adaptive immune system, the key to treating Alzheimer’s might be to address the dysregulated innate immune system due to chronic inflammation. R.J. talks about…Read More
Tackling Neuroinflammation to Reduce Pathological Brain Changes in Alzheimer’s Patients with Dr. R.J. Tesi INmune Bio
Apr 26, 2021
Dr. R.J. Tesi, President and CEO, INmune Bio shines light on the complexity of the immune system by pointing out that while much work has been done on the adaptive immune system, the key to treating Alzheimer’s might be to address the dysregulated innate immune system due to chronic inflammation. R.J. talks about…Read More
Creativity and Mental Health Disorders with Mary Guillermin Mental Health Advocate Pellin Institute TRANSCRIPT
Apr 25, 2021
Mary Guillermin, Director of Communications and Senior Pellin Practicioner at the Pellin Institute International and author talks about her book John Guillermin: The Man, The Myth, The Movies a story about her husband the British writer and film director of such films as King Kong, The Towering Inferno, The Blue Max and…Read More
Creativity and Mental Health Disorders with Mary Guillermin Mental Health Advocate Pellin Institute
Apr 25, 2021
Mary Guillermin, Director of Communications and Senior Pellin Practicioner at the Pellin Institute International and author talks about her book John Guillermin: The Man, The Myth, The Movies a story about her husband the British writer and film director of such films as King Kong, The Towering Inferno, The Blue Max and…Read More
Developing Microbiome Therapeutics to Improve Efficacy of Drugs and Vaccines with Stephanie Culler Persephone Biosciences TRANSCRIPT
Apr 21, 2021
Stephanie Culler PhD, Co-Founder and CEO, Persephone Biosciences describes how the microbiome, the microbes that exist in our GI tract, impacts our overall health and specifically the immune system. Their goal is to leverage the impact of a healthy microbiome to improve the effectiveness of drugs and vaccines. By…Read More
Developing Microbiome Therapeutics to Improve Efficacy of Drugs and Vaccines with Stephanie Culler Persephone Biosciences
Apr 21, 2021
Stephanie Culler PhD, Co-Founder and CEO, Persephone Biosciences describes how the microbiome, the microbes that exist in our GI tract, impacts our overall health and specifically the immune system. Their goal is to leverage the impact of a healthy microbiome to improve the effectiveness of drugs and vaccines. By…Read More
Treating Alzheimer’s and Parkinson’s by Addressing Axonal Transport to Protect Nerve Cells from Dying with Maria Maccecchini Annovis Bio TRANSCRIPT
Apr 20, 2021
Maria Maccecchini PhD, Founder, President, CEO, Annovis Bio has been on the path to find a way to protect nerve cells to maintain overall health. Lead therapy ANVS401 (phase 2) is designed to treat Alzheimer’s, Parkinson’s and other neurodegenerative diseases by tapping into the brain’s defense mechanism to get rid of…Read More
Treating Alzheimer’s and Parkinson’s by Addressing Axonal Transport to Protect Nerve Cells from Dying with Maria Maccecchini Annovis Bio
Apr 20, 2021
Maria Maccecchini PhD, Founder, President, CEO, Annovis Bio has been on the path to find a way to protect nerve cells to maintain overall health. Lead therapy ANVS401 (phase 2) is designed to treat Alzheimer’s, Parkinson’s and other neurodegenerative diseases by tapping into the brain’s defense mechanism to get rid of…Read More
Moving from Precision Medicine to Personalized Drugs to Fight Driver Mutations in Cancer with Usama Malik Fore Biotherapeutics TRANSCRIPT
Apr 19, 2021
Usama Malik, CEO, Fore Biotherapeutics is aiming to treat patients with rare cancer mutations with a hyper targeted precision or personalized approach by using the Fore AI-based technology platform to investigate which drugs might work best for each mutation. While most cancer companies focus only on the most prevalent…Read More
Moving from Precision Medicine to Personalized Drugs to Fight Driver Mutations in Cancer with Usama Malik Fore Biotherapeutics
Apr 19, 2021
Usama Malik, CEO, Fore Biotherapeutics is aiming to treat patients with rare cancer mutations with a hyper targeted precision or personalized approach by using the Fore AI-based technology platform to investigate which drugs might work best for each mutation. While most cancer companies focus only on the most prevalent…Read More
Connected Nursery Ecosystem Generating Valuable Data for Parents and Researchers with Kurt Workman Owlet TRANSCRIPT
Apr 15, 2021
Kurt Workman, Co-Founder and CEO, Owlet describes a digital healthcare platform for parents of infants that is part of a connected nursery ecosystem providing critical and reassuring real-time and archived data about the baby. The pulse oximetry technology in their anchor product Smart Sock allows parents to track the…Read More
Connected Nursery Ecosystem Generating Valuable Data for Parents and Researchers with Kurt Workman Owlet
Apr 15, 2021
Kurt Workman, Co-Founder and CEO, Owlet describes a digital healthcare platform for parents of infants that is part of a connected nursery ecosystem providing critical and reassuring real time and archived data about the baby. The pulse oximetry technology in their anchor product Smart Sock allows parents to track the…Read More
Arizona Surge Line Successfully Manages COVID-19 Patient Population Access to Care with Luke Smith Central Logic TRANSCRIPT
Apr 14, 2021
Luke Smith, Client Operations Analyst, Central Logic and the Director of the Arizona Surge Line finally has time to reflect on the work that went into managing access to hospitals and post-acute care for patients suffering from COVID-10 throughout the state of Arizona, at one point the number 1 hot spot in the world for…Read More
Arizona Surge Line Successfully Manages COVID-19 Patient Population Access to Care with Luke Smith Central Logic
Apr 14, 2021
Luke Smith, Client Operations Analyst, Central Logic and the Director of the Arizona Surge Line finally has time to reflect on the work that went into managing access to hospitals and post-acute care for patients suffering from COVID-10 throughout the state of Arizona, at one point the number 1 hot spot in the world for…Read More
Advocating for Patients with Rare Neurological Disease LEMS with Amy Grover Catalyst Pharmaceuticals TRANSCRIPT
Apr 13, 2021
Amy Grover, Director of Patient Advocacy, Catalyst Pharmaceuticals works primarily with patients suffering from Lambert-Eaton Myasthenic Syndrome LEMS an ultra-rare disease which is very similar to a larger rare disease myasthenia gravis MG. Working with the patient community and patient advocacy groups, Catalyst is…Read More
Advocating for Patients with Rare Neurological Disease LEMS with Amy Grover Catalyst Pharmaceuticals
Apr 13, 2021
Amy Grover, Director of Patient Advocacy, Catalyst Pharmaceuticals works primarily with patients suffering from Lambert-Eaton Myasthenic Syndrome LEMS an ultra-rare disease which is very similar to a larger rare disease myasthenia gravis MG. Working with the patient community and patient advocacy groups, Catalyst is…Read More
Solving the COVID-19 Pandemic as a Data Science Problem with Sally Embrey DataRobot TRANSCRIPT
Apr 12, 2021
Sally Embrey, Vice President Public Health and Health Tech, DataRobot is applying knowledge from work as an enterprise AI company to attacking the problem of containing and defeating COVID-19. ContagionNET was created to identify leading and lagging indicators of the next COVID-19 hotspot and to help people understand…Read More
Solving the COVID-19 Pandemic as a Data Science Problem with Sally Embrey DataRobot
Apr 12, 2021
Sally Embrey, Vice President Public Health and Health Tech, DataRobot is applying knowledge from work as an enterprise AI company to attacking the problem of containing and defeating COVID-19. ContagionNET was created to identify leading and lagging indicators of the next COVID-19 hotspot and to help people understand…Read More
Treating Schizophrenia by Mitigating Peripheral Side Effects from Existing Antipsychotics with Dr. Stephen Brannan Karuna Therapeutics TRANSCRIPT
Apr 7, 2021
Dr. Stephen Brannan, Chief Medical Officer, Karuna Therapeutics discusses the need for creating and delivering transformative medicines for people living with psychiatric and neurological conditions particularly schizophrenia. Pairing the muscarinic agonist with a pan-cholinergic antagonist that does not cross into the…Read More
Treating Schizophrenia by Mitigating Peripheral Side Effects from Existing Antipsychotics with Dr. Stephen Brannan Karuna Therapeutics
Apr 7, 2021
Dr. Stephen Brannan, Chief Medical Officer, Karuna Therapeutics discusses the need for creating and delivering transformative medicines for people living with psychiatric and neurological conditions particularly schizophrenia. Pairing the muscarinic agonist with a pan-cholinergic antagonist that does not cross into the…Read More
Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Diseases with Jonathan Rigby Revolo Biotherapeutics TRANSCRIPT
Apr 6, 2021
Jonathan Rigby, CEO, Revolo Biotherapeutics discusses the company’s revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, with less frequent chronic dosing and without suppression of the immune system. A goal that others…Read More
Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Diseases with Jonathan Rigby Revolo Biotherapeutics
Apr 6, 2021
Jonathan Rigby, CEO, Revolo Biotherapeutics discusses the company’s revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, with less frequent chronic dosing and without suppression of the immune system. A goal that others…Read More
Virtual Diabetes Management Providing Insights About Chemical and Cognitive Aspects with Anthony Comfort VisiQuate TRANSCRIPT
Apr 5, 2021
Anthony Comfort, VP Product Management, VisiQuate reflects on how far science and technology have come in helping monitor the health of diabetics with a new understanding of chemical changes in the body as well as cognitive and behavioral aspects. With the change from manual monitoring blood glucose readings to…Read More
Virtual Diabetes Management Providing Insights About Chemical and Cognitive Aspects with Anthony Comfort VisiQuate
Apr 5, 2021
Anthony Comfort, VP Product Management, VisiQuate reflects on how far science and technology have come in helping monitor the health of diabetics with a new understanding of chemical changes in the body as well as cognitive and behavioral aspects. With the change from manual monitoring blood glucose readings to…Read More
Advanced Skin Cancer Diagnostic Tests Overlay Biology on Top of Pathology to Determine Appropriate Treatment With Derek Maetzold Castle Bio TRANSCRIPT
Mar 31, 2021
Derek Maetzold, President and CEO, Castle Biosciences is harnessing the power of genomics to understand the biology of skin cancer. Castle has developed genomic tests to determine how aggressive melanoma and squamous cell carcinoma are in order to better inform dermatologist and patients about intervention decisions….Read More
Advanced Skin Cancer Diagnostic Tests Overlay Biology on Top of Pathology to Determine Appropriate Treatment With Derek Maetzold Castle Bio
Mar 31, 2021
Derek Maetzold, President and CEO, Castle Biosciences is harnessing the power of genomics to understand the biology of skin cancer. Castle has developed genomic tests to determine how aggressive melanoma and squamous cell carcinoma are in order to better inform dermatologist and patients about intervention decisions….Read More
Relationship Between Genetics the Endocannabinoid System and Impact of Cannabis with Len May Endocanna Health TRANSCRIPT
Mar 31, 2021
Len May, CEO, EndoCanna Health is aggressively exploring the genes that are associated with metabolism of cannabinoids and aiming for a better understanding of the endocannabinoid system to guide the use of cannabis for a wide range of conditions and disorders. With an eye to the complexity of the cannabis plant,…Read More
Relationship Between Genetics the Endocannabinoid System and Impact of Cannabis with Len May Endocanna Health
Mar 31, 2021
Len May, CEO, EndoCanna Health is aggressively exploring the genes that are associated with metabolism of cannabinoids and aiming for a better understanding of the endocannabinoid system to guide the use of cannabis for a wide range of conditions and disorders. With an eye to the complexity of the cannabis plant,…Read More
Biosynthesizing Psilocybin to Treat Mental Illness and Other Neurological Disorders with Evan Levine PsyBio Therapeutics TRANSCRIPT
Mar 30, 2021
Evan Levine, Co-Founder and CEO, PsyBio Therapeutics is pursuing a paradigm shift in the treatment of mental illness and other neurological disorders by using psychedelics and hallucinogenics. PsyBio biosynthesizes psilocybin and other psychoactive drugs from different plants and fungi from genetically-modified…Read More
Biosynthesizing Psilocybin to Treat Mental Illness and Other Neurological Disorders with Evan Levine PsyBio Therapeutics
Mar 30, 2021
Evan Levine, Co-Founder and CEO, PsyBio Therapeutics is pursuing a paradigm shift in the treatment of mental illness and other neurological disorders by using psychedelics and hallucinogenics. PsyBio biosynthesizes psilocybin and other psychoactive drugs from different plants and fungi from genetically-modified…Read More
Ensuring a Safe Return to Work Stay at Work Environment During the Pandemic with Michael Tkach Affinity TRANSCRIPT
Mar 29, 2021
Michael Tkach, Chief Operating Officer and Chief Behavioral Health Officer, Affinity describes a variety of models for large-scale population healthcare management for Return to Work/Stay at Work in this time of COVID-19. With continuous monitoring, testing and data analysis, risk assessment is being used to keep…Read More
Ensuring a Safe Return to Work Stay at Work Environment During the Pandemic with Michael Tkach Affinity
Mar 29, 2021
Michael Tkach, Chief Operating Officer and Chief Behavioral Health Officer, Affinity describes a variety of models for large-scale population healthcare management for Return to Work/Stay at Work in this time of COVID-19. With continuous monitoring, testing and data analysis, risk assessment is being used to keep…Read More
New Treatment Option for Spinal Muscular Atrophy with Dr. Greg Rippon Genentech TRANSCRIPT
Mar 25, 2021
Dr. Greg Rippon, Vice President and Chief Medical Partner of Neurology, Genentech shines light on SMA, spinal muscular atrophy, a severe inherited progressive neuromuscular disease and one of the most common rare diseases affecting babies. With the introduction of Evrysdi to the treatment options for SMA, an oral…Read More
New Treatment Option for Spinal Muscular Atrophy with Dr. Greg Rippon Genentech
Mar 25, 2021
Dr. Greg Rippon, Vice President and Chief Medical Partner of Neurology, Genentech shines light on SMA, spinal muscular atrophy, a severe inherited progressive neuromuscular disease and one of the most common rare diseases affecting babies. With the introduction of Evrysdi to the treatment options for SMA, an oral…Read More
Targeting and Modulating CRAC Channels to Treat Acute Pancreatitis and COVID-19 with Dr. Sudarshan Hebbar CalciMedica TRANSCRIPT
Mar 24, 2021
Dr. Sudarshan Hebbar, Chief Medical Officer, CalciMedica talks about developing drugs that are focused on targeting CRAC channels, calcium release activated calcium channels, in order to modulate these channels to help treat diseases that have a significant inflammatory component. Initially developed drugs for acute…Read More
Targeting and Modulating CRAC Channels to Treat Acute Pancreatitis and COVID-19 with Dr. Sudarshan Hebbar CalciMedica
Mar 24, 2021
Dr. Sudarshan Hebbar, Chief Medical Officer, CalciMedica talks about developing drugs that are focused on targeting CRAC channels, calcium release activated calcium channels, in order to modulate these channels to help treat diseases that have a significant inflammatory component. Initially developed drugs for acute…Read More
Meeting Unmet Needs of Neurodegeneration and Disorders of Cognition by Targeting the NMDA Receptor with Dr. Aaron Koenig and Mike Quirk Sage Therapeutics TRANSCRIPT
Mar 23, 2021
Dr. Aaron Koenig, Senior Medical Director and Mike Quirk, Vice President of pharmacology Sage Therapeutics focus on disorders of cognition and diseases that reflect determinants of impaired cognition such as Alzheimer’s, Parkinson’s and Huntington’s. Their drug Sage-718, a novel mechanism of action, targets a protein in…Read More
Meeting Unmet Needs of Neurodegeneration and Disorders of Cognition by Targeting the NMDA Receptor with Dr. Aaron Koenig and Mike Quirk Sage Therapeutics
Mar 23, 2021
Dr. Aaron Koenig, Senior Medical Director and Mike Quirk, Vice President of pharmacology Sage Therapeutics focus on disorders of cognition and diseases that reflect determinants of impaired cognition such as Alzheimer’s, Parkinson’s and Huntington’s. Their drug Sage-718, a novel mechanism of action, targets a protein in…Read More
New Long-Acting Methylphenidate Prodrug to Treat ADHD with Dr. Travis Mickle KemPharm TRANSCRIPT
Mar 22, 2021
Dr. Travis Mickle President and CEO KemPharm describes the development of AZSTARYS, the stimulant-based methylphenidate prodrug treatment for ADHD one of the most common central nervous system diseases. This prodrug stimulates the norepinephrine dopamine reuptake inhibitor improving concentration, executive function,…Read More
New Long-Acting Methylphenidate Prodrug to Treat ADHD with Dr. Travis Mickle KemPharm
Mar 22, 2021
Dr. Travis Mickle President and CEO KemPharm describes the development of AZSTARYS, the stimulant-based methylphenidate prodrug treatment for ADHD one of the most common central nervous system diseases. This prodrug stimulates the norepinephrine dopamine reuptake inhibitor improving concentration, executive function,…Read More
Developing Recombinant GDF11 to Promote Healthy Vasculature and Treat Age-Related Diseases with Dr. Mark Allen Elevian TRANSCRIPT
Mar 18, 2021
Dr. Mark Allen, Co-Founder and CEO, Elevian is looking to disrupt the longevity business by developing a recombinant GDF11 to treat and prevent multiple age-related diseases. The first application being investigated is for stroke recovery drawing on the discovery that GDF11 decreases with age and when replenished,…Read More
Developing Recombinant GDF11 to Promote Healthy Vasculature and Treat Age-Related Diseases with Dr. Mark Allen Elevian
Mar 18, 2021
Dr. Mark Allen, Co-Founder and CEO, Elevian is looking to disrupt the longevity business by developing a recombinant GDF11 to treat and prevent multiple age-related diseases. The first application being investigated is for stroke recovery drawing on the discovery that GDF11 decreases with age and when replenished,…Read More
Breakthrough Therapy for Treating Major Depressive Disorder with Dr. Steve Kanes Sage Therapeutics TRANSCRIPT
Mar 17, 2021
Dr. Steve Kanes, Chief Medical Officer, Sage Therapeutics takes the view that mental disorders and brain health disorders need to be treated like any other medicine. Driving this paradigm shift is the development of breakthrough zuranalone, an oral limited-time treatment to replace taking medicine chronically for those…Read More
Breakthrough Therapy for Treating Major Depressive Disorder with Dr. Steve Kanes Sage Therapeutics
Mar 17, 2021
Dr. Steve Kanes, Chief Medical Officer, Sage Therapeutics takes the view that mental disorders and brain health disorders need to be treated like any other medicine. Driving this paradigm shift is the development of breakthrough zuranalone, an oral limited-time treatment to replace taking medicine chronically for those…Read More
Using Blockchain to Secure Health Record Access and Sharing with Louis Martinez EHR Data TRANSCRIPT
Mar 16, 2021
Louis Martinez, Chief Information Officer, EHR Data shines a light on the decentralization of healthcare data collected by providers, insurance carriers, pharmacists and other medical service providers. With a goal of centralizing disparate health data and providing access at point of care, EHR is using blockchain to…Read More
Using Blockchain to Secure Health Record Access and Sharing with Louis Martinez EHR Data
Mar 16, 2021
Louis Martinez, Chief Information Officer, EHR Data shines a light on the decentralization of healthcare data collected by providers, insurance carriers, pharmacists and other medical service providers. With a goal of centralizing disparate health data and providing access at point of care, EHR is using blockchain to…Read More
Developing Accessible Monoclonal Antibodies to Treat COVID-19 with Vu Truong Aridis Pharmaceuticals TRANSCRIPT
Mar 15, 2021
Vu Truong, CEO, Aridis Pharmaceuticals is taking on the challenge of making an inhaled monoclonal antibody to treat COVID-19 to allow for the easier patient access. Drawing on their work in infectious diseases and with a number of monoclonal antibodies candidates to treat bacteria infection associated with superbugs…Read More
Developing Accessible Monoclonal Antibodies to Treat COVID-19 with Vu Truong Aridis Pharmaceuticals
Mar 15, 2021
Vu Truong, CEO, Aridis Pharmaceuticals is taking on the challenge of making an inhaled monoclonal antibody to treat COVID-19 to allow for the easier patient access. Drawing on their work in infectious diseases and with a number of monoclonal antibodies candidates to treat bacteria infection associated with superbugs…Read More
Optimizing Health System Resources for Patients Needing Acute Care with Niloy Sanyal LeanTaaS TRANSCRIPT
Mar 10, 2021
Niloy Sanyal, Chief Marketing Officer, LeanTaaS is focused on the current state of the healthcare system in this wartime environment. In light of COVID-19 challenges particularly for those patients needing acute care, the need to optimize use of operating rooms, ICU beds, infusion chairs, and medical professionals…Read More
Optimizing Health System Resources for Patients Needing Acute Care with Niloy Sanyal LeanTaaS
Mar 10, 2021
Niloy Sanyal, Chief Marketing Officer, LeanTaaS is focused on the current state of the healthcare system in this wartime environment. In light of COVID-19 challenges particularly for those patients needing acute care, the need to optimize use of operating rooms, ICU beds, infusion chairs, and medical professionals…Read More
Building Digitally-Enabled Healthcare Tools to Serve a Global Audience with Mariya Pylypiv UpHealth TRANSCRIPT
Mar 7, 2021
Mariya Pylypiv, Founder and Co-Chairwoman, UpHealth talks about empowering patients suffering from chronic conditions with a global comprehensive digital health technology and tech-enabled services platform. Working with care providers, health systems and payers, UpHealth is addressing the complex medical, behavioral,…Read More
Building Digitally-Enabled Healthcare Tools to Serve a Global Audience with Mariya Pylypiv UpHealth
Mar 7, 2021
Mariya Pylypiv, Founder and Co-Chairwoman, UpHealth talks about empowering patients suffering from chronic conditions with a global comprehensive digital health technology and tech-enabled services platform. Working with care providers, health systems and payers, UpHealth is addressing the complex medical, behavioral,…Read More
Using Biosimulation to Develop Pediatric Therapeutics with Lynne Georgopoulos Certara TRANSCRIPT
Mar 3, 2021
Lynne Georgopoulos, VP Regulatory Strategy, Certara describes the company’s platform to optimize pediatric drug development using biosimulation. With an eye on pediatric diseases, Certara is employing modeling and simulation to determine how a drug developed for adults may be metabolized in children, including…Read More
Using Biosimulation to Develop Pediatric Therapeutics with Lynne Georgopoulos Certara
Mar 3, 2021
Lynne Georgopoulos, VP Regulatory Strategy, Certara describes the company’s platform to optimize pediatric drug development using biosimulation. With an eye on pediatric diseases, Certara is employing modeling and simulation to determine how a drug developed for adults may be metabolized in children, including…Read More
COVID-19 Driving More Posture Related Disorders with Dr. Romina Ghassemi Think Healthy TRANSCRIPT
Mar 1, 2021
Dr. Romina Ghassemi, chiropractor and founder of Think Healthy is an expert on posture and is raising awareness about the need to address the health of the full spine along with solutions to address stress and related diseases. Her traditional business has been with the aging population to reduce pain and insure…Read More
COVID-19 Driving More Posture Related Disorders with Dr. Romina Ghassemi Think Healthy
Mar 1, 2021
Dr. Romina Ghassemi, chiropractor and founder of Think Healthy is an expert on posture and is raising awareness about the need to address the health of the full spine along with solutions to address stress and related diseases. Her traditional business has been with the aging population to reduce pain and insure…Read More
Developing Oral Drugs for Neurodegenerative Diseases Based on Bioenergetic Nanotherapeutics with Mark Mortenson Clene Nanomedicine TRANSCRIPT
Feb 24, 2021
Mark Mortenson, Chief Science Officer, Clene Nanomedicine is combining physics with biology to develop its bioenergetic nanocatalyst drug candidates that accelerate neurorepair for patients with neurodegenerative disease. Using gold nanocrystals, the company is able to amplify bioenergetic reactions in patients that…Read More
From Beepers to Mobile Phones and the Future of Digital Health with Martin Cooper Inventor, Entrepreneur and Author TRANSCRIPT
Feb 23, 2021
Martin Cooper, inventor, entrepreneur, and author of Cutting the Cord: The Cell Phone has Transformed Humanity reminds us of the twisted path the mobile phone has taken from the early roots of beepers, pagers, and car phones to the current form allowing for mobile health innovations. As the inventor of the DynaTAC, the…Read More
From Beepers to Mobile Phones and the Future of Digital Health with Martin Cooper Inventor, Entrepreneur and Author
Feb 23, 2021
Martin Cooper, inventor, entrepreneur, and author of Cutting the Cord: The Cell Phone has Transformed Humanity reminds us of the twisted path the mobile phone has taken from the early roots of beepers, pagers, and car phones to the current form allowing for mobile health innovations. As the inventor of the DynaTAC, the…Read More
Developing Oral Drugs for Neurodegenerative Diseases Based on Bioenergetic Nanotherapeutics with Mark Mortenson Clene Nanomedicine
Feb 23, 2021
Mark Mortenson, Chief Science Officer, Clene Nanomedicine is combining physics with biology to develop its bioenergetic nanocatalyst drug candidates that accelerate neurorepair for patients with neurodegenerative disease. Using gold nanocrystals, the company is able to amplify bioenergetic reactions in patients that…Read More
Business of Running a Hospital or Health System During a Pandemic with Walt Ellenberger SAP TRANSCRIPT
Feb 22, 2021
Walt Ellenberger, Senior Director of Business Development and Strategic Alliance, SAP, sheds light on the new challenges in the healthcare environment as a result of COVID-19 on top of the move from quantity to quality of service and the changes already underway from being a doctor-centric to patient focused delivery…Read More
Business of Running a Hospital or Health System During a Pandemic with Walt Ellenberger SAP
Feb 22, 2021
Walt Ellenberger, Senior Director of Business Development and Strategic Alliance, SAP, sheds light on the new challenges in the healthcare environment as a result of COVID-19 on top of the move from quantity to quality of service and the changes already underway from being a doctor-centric to patient focused delivery…Read More
Long-Term Post-Acute and Home Health Care Challenges and Opportunities with Mary Henschel PointClickCare TRANSCRIPT
Feb 17, 2021
Mary Henschel, Director of Home Health Strategy, PointClickCare brings an understanding of the value of technology to the long-term post-acute care (LTPAC) and home health environments. Looking at the spectrum of required care from short-term rehabilitation, to skilled nursing facilities, to bringing the SNF experience…Read More
Long-Term Post-Acute and Home Health Care Challenges and Opportunities with Mary Henschel PointClickCare
Feb 17, 2021
Mary Henschel, Director of Home Health Strategy, PointClickCare brings an understanding of the value of technology to the long-term post-acute care (LTPAC) and home health environments. Looking at the spectrum of required care from short-term rehabilitation, to skilled nursing facilities, to bringing the SNF experience…Read More
Optical Coherence Tomography Provides Intravascular Imaging with Unparalleled Granularity with Dr. Nick West Abbott TRANSCRIPT
Feb 16, 2021
Dr. Nick West, Chief Medical Officer and DVP, Global Medical Affairs, Vascular Division, Abbott reveals the advances over traditional angiograms that Abbott is bringing to the market that change the ability to see inside blood vessels. Using the Optical Coherence Tomography (OCT) to examine coronary arteries,…Read More
Optical Coherence Tomography Provides Intravascular Imaging with Unparalleled Granularity with Dr. Nick West Abbott
Feb 16, 2021
Dr. Nick West, Chief Medical Officer and DVP, Global Medical Affairs, Vascular Division, Abbott reveals the advances over traditional angiograms that Abbott is bringing to the market that change the ability to see inside blood vessels. Using the Optical Coherence Tomography (OCT) to examine coronary arteries,…Read More
Attacking COVID-19 Virus Hiding in the Gastrointestinal Tract of Long-Haulers with James Sapirstein AzurRx BioPharma TRANSCRIPT
Feb 15, 2021
James Sapirstein, President and CEO, AzurRx BioPharma, a clinical stage biopharmaceutical company specializing in therapies for gastrointestinal diseases talks about turning their focus to the virus that causes COVID-19. With a background in drug development for HIV and infectious diseases, James describes their…Read More
Attacking COVID-19 Virus Hiding in the Gastrointestinal Tract of Long-Haulers with James Sapirstein AzurRx BioPharma
Feb 15, 2021
James Sapirstein, President and CEO, AzurRx BioPharma, a clinical stage biopharmaceutical company specializing in therapies for gastrointestinal diseases talks about turning their focus to the virus that causes COVID-19. With a background in drug development for HIV and infectious diseases, James describes their…Read More
Reinventing Body Repair and Tissue Reconstruction with Christophe Bancel TISSIUM TRANSCRIPT
Feb 10, 2021
Christophe Bancel, Co-Founder and CEO, TISSIUM is determined to change the way body and tissue repair during surgical procedures is conducted. Rather than the old techniques such as suturing, stapling and screwing that induce trauma to the body, TISSIUM believes that tissue reconstruction should be atraumatic. …Read More
Reinventing Body Repair and Tissue Reconstruction with Christophe Bancel TISSIUM
Feb 10, 2021
Christophe Bancel, Co-Founder and CEO, TISSIUM is determined to change the way body and tissue repair during surgical procedures is conducted. Rather than the old techniques such as suturing, stapling and screwing that induce trauma to the body, TISSIUM believes that tissue reconstruction should be atraumatic. …Read More
Developing a Universal Influenza Vaccine with Joseph Hernandez Blue Water Vaccines TRANSCRIPT
Feb 9, 2021
Joseph Hernandez, Founder and CEO, Blue Water Vaccines identifies the underlying discover about the nature of the influenza virus which is driving the development of a novel universal flu vaccine that would be administered once for lifelong immunization. The economic and health implications of this vaccine include…Read More
Developing a Universal Influenza Vaccine with Joseph Hernandez Blue Water Vaccines
Feb 9, 2021
Joseph Hernandez, Founder and CEO, Blue Water Vaccines identifies the underlying discover about the nature of the influenza virus which is driving the development of a novel universal flu vaccine that would be administered once for lifelong immunization. The economic and health implications of this vaccine include…Read More
Developing Potent Oral Kinase Inhibitor to Treat Recurrent Difficult to Treat Brain Cancer with Scott Megaffin Adastra Pharmaceuticals TRANSCRIPT
Feb 8, 2021
Scott Megaffin, CEO, Adastra Pharmaceuticals has taken on the challenge of developing first-in-class innovative therapeutics for the treatment of cancers with high unmet needs such as high-grade gliomas. He talks about the Phase 1b clinical trial conducted by the National Cancer Institute evaluating zotiraciclib, a…Read More
Developing Potent Oral Kinase Inhibitor to Treat Recurrent Difficult to Treat Brain Cancer with Scott Megaffin Adastra Pharmaceuticals
Feb 8, 2021
Scott Megaffin, CEO, Adastra Pharmaceuticals has taken on the challenge of developing first-in-class innovative therapeutics for the treatment of cancers with high unmet needs such as high-grade gliomas. He talks about the Phase 1b clinical trial conducted by the National Cancer Institute evaluating zotiraciclib, a…Read More
Healthcare Data Interoperability Driven by Transformative Cures Act Patient Access Rule with Eric Rosow Diameter Health TRANSCRIPT
Feb 3, 2021
Eric Rosow, CEO and Co-Founder, Diameter Health shines light on the new ONC Cures Act and the significance of the Patient Access rule that mandates interoperability technology standards for payers. The primary purpose of the interoperability rules is to enable patients to have secure access to their own health data. …Read More
Healthcare Data Interoperability Driven by Transformative Cures Act Patient Access Rule with Eric Rosow Diameter Health
Feb 3, 2021
Eric Rosow, CEO and Co-Founder, Diameter Health shines light on the new ONC Cures Act and the significance of the Patient Access rule that mandates interoperability technology standards for payers. The primary purpose of the interoperability rules is to enable patients to have secure access to their own health data. …Read More
Investing in Transformative Oncology Therapies with Maina Bhaman Sofinnova Partners TRANSCRIPT
Feb 2, 2021
Maina Bhaman, Partner, Capital Funds, Sofinnova Partners has a long record as a successful healthcare investor in oncology, hearing, cardiovascular and cell and gene therapy. She talks about their recent investments in Myricx Pharma, a startup from Imperial College and the Francis Crick Institute in London focused on…Read More
Investing in Transformative Oncology Therapies with Maina Bhaman Sofinnova Partners
Feb 2, 2021
Maina Bhaman, Partner, Capital Funds, Sofinnova Partners has a long record as a successful healthcare investor in oncology, hearing, cardiovascular and cell and gene therapy. She talks about their recent investments in Myricx Pharma, a startup from Imperial College and the Francis Crick Institute in London focused on…Read More
Using Medical Gaming to Monitor Chronic Eye Disease of Aging with Edouard Gasser Tilak Healthcare TRANSCRIPT
Jan 27, 2021
Edouard Gasser, CEO, Tilak Healthcare comes from the video gaming industry and is applying his knowledge about engaging mobile game players to an audience of those suffering from eye diseases of aging like AMD, age-related macular disease, or diabetic retinopathy. Using the OdySight game prescribed by an…Read More
Using Medical Gaming to Monitor Chronic Eye Disease of Aging with Edouard Gasser Tilak Healthcare
Jan 27, 2021
Edouard Gasser, CEO, Tilak Healthcare comes from the video gaming industry and is applying his knowledge about engaging mobile game players to an audience of those suffering from eye diseases of aging like AMD, age-related macular disease, or diabetic retinopathy. Using the OdySight game prescribed by an…Read More
Supporting Complex Populations with Advanced Care Management Platform with Adam Sabloff VirtualHealth TRANSCRIPT
Jan 25, 2021
Adam Sabloff, CEO and Founder, VirtualHealth works with health plans and care managers to facilitate strong relationships with patients covered by Medicare and Medicaid. The HELIOS® care management platform aggregates data across the healthcare continuum to create a centralized patient record allowing for interventions…Read More
Supporting Complex Populations with Advanced Care Management Platform with Adam Sabloff VirtualHealth
Jan 25, 2021
Adam Sabloff, CEO and Founder, VirtualHealth works with health plans and care managers to facilitate strong relationships with patients covered by Medicare and Medicaid. The HELIOS® care management platform aggregates data across the healthcare continuum to create a centralized patient record allowing for interventions…Read More
Making Pediatric Cancer Survivable with Dr. Charles Keller Children’s Cancer Therapy Development Institute TRANSCRIPT
Jan 20, 2021
Dr. Charles Keller, Scientific Director, Children’s Cancer Therapy Development Institute is working with a diverse team in this non-profit biotech to make all childhood cancers universally survivable. Filling the preclinical gap, cc-TDI is moving drugs for pediatric brain tumors and muscle cancers into national…Read More
Making Pediatric Cancer Survivable with Dr. Charles Keller Children’s Cancer Therapy Development Institute
Jan 20, 2021
Dr. Charles Keller, Scientific Director, Children’s Cancer Therapy Development Institute is working with a diverse team in this non-profit biotech to make all childhood cancers universally survivable. Filling the preclinical gap, cc-TDI is moving drugs for pediatric brain tumors and muscle cancers into national…Read More
Lessons from Early Days of Treating COVID-19 with Dr. Teresa Girolami BelRed Internal Medicine TRANSCRIPT
Jan 19, 2021
Dr. Teresa Girolami, Founder and CEO, BelRed Internal Medicine and Co-Founder Sound Health Solutions is an internist in Washington State and on the staff at Evergreen Hospital, the first hospital in the US to identify the COVID-19 virus. She points out lessons learned about the use of ventilators, the value of testing,…Read More
Lessons from Early Days of Treating COVID-19 with Dr. Teresa Girolami BelRed Internal Medicine
Jan 19, 2021
Dr. Teresa Girolami, Founder and CEO, BelRed Internal Medicine and Co-Founder Sound Health Solutions is an internist in Washington State and on the staff at Evergreen Hospital, the first hospital in the US to identify the COVID-19 virus. She points out lessons learned about the use of ventilators, the value of testing,…Read More
Treating Severe Respiratory Failure in COVID-19 Patients with Dr. Jonathan Javitt NeuroRx TRANSCRIPT
Jan 18, 2021
Dr. Jonathan Javitt, Founder, Chairman and CEO, NeuroRx talks about drawing on their work developing novel therapeutics for bipolar depression and respiratory disease to focus on a therapy, aviptadil also known as ZYESAMI, for critical COVID-19 especially those with advanced comorbidities. This peptide hormone VIP…Read More
Treating Severe Respiratory Failure in COVID-19 Patients with Dr. Jonathan Javitt NeuroRx
Jan 18, 2021
Dr. Jonathan Javitt, Founder, Chairman and CEO, NeuroRx talks about drawing on their work developing novel therapeutics for bipolar depression and respiratory disease to focus on a therapy, aviptadil also known as ZYESAMI, for critical COVID-19 especially those with advanced comorbidities. This peptide hormone VIP…Read More
Impact of Implementation of Price Transparency by Hospitals and Health Plans with Lillian Phelps Availity TRANSCRIPT
Jan 13, 2021
Lillian Phelps, Senior Director of Product Management, Availity shines light on the new HHS rules about price transparency for hospitals and health plans. These organizations now need to publish their standard rates as well as their contracted rates along with pricing for bundled services for over 70 specific services….Read More
Impact of Implementation of Price Transparency by Hospitals and Health Plans with Lillian Phelps Availity
Jan 13, 2021
Lillian Phelps, Senior Director of Product Management, Availity shines light on the new HHS rules about price transparency for hospitals and health plans. These organizations now need to publish their standard rates as well as their contracted rates along with pricing for bundled services for over 70 specific services….Read More
Advanced Antibody Discovery Platform Generates COVID-19 Antibody Therapy with Ian Chan Abpro TRANSCRIPT
Jan 11, 2021
Ian Chan, CEO, Abpro is developing a drug which is a COVID-19 neutralizing antibody that has demonstrated strong binding affinity for COVID-19 in a Phase 2/3 global trial. Using the Diverse Immune Platform, an advanced antibody discovery platform, Abpro is drawing on years of successful work developing neutralizing…Read More
Advanced Antibody Discovery Platform Generates COVID-19 Antibody Therapy with Ian Chan Abpro
Jan 11, 2021
Ian Chan, CEO, Abpro is developing a drug which is a COVID-19 neutralizing antibody that has demonstrated strong binding affinity for COVID-19 in a Phase 2/3 global trial. Using the Diverse Immune Platform, an advanced antibody discovery platform, Abpro is drawing on years of successful work developing neutralizing…Read More
New Normal for Informing Family Members About Care Team and Patient Progress with Hope Johnson Lehigh Valley Health Network TRANSCRIPT
Jan 8, 2021
Hope Johnson, Administrator Perioperative Services, Lehigh Valley Health Network has deployed the Vocera Ease app to facilitate updates for family members about patient progress in surgery. Since they began implementing this solution in 2017, LVNH was prepared for the increased restrictions from COVID-19 on the ability…Read More
New Normal for Informing Family Members About Care Team and Patient Progress with Hope Johnson Lehigh Valley Health Network
Jan 8, 2021
Hope Johnson, Administrator Perioperative Services, Lehigh Valley Health Network has deployed the Vocera Ease app to facilitate updates for family members about patient progress in surgery. Since they began implementing this solution in 2017, LVNH was prepared for the increased restrictions from COVID-19 on the ability…Read More
Superficial Radiation Therapy Strong Alternative to Mohs Surgery for Skin Cancer with Joseph Sardano Sensus Healthcare TRANSCRIPT
Jan 6, 2021
Joseph Sardano, Founder and CEO, Sensus Healthcare presents compelling data on the effectiveness of a non-surgical alternative to Mohs surgery for treating skin cancer and keloids. Using Superficial Radiation Therapy otherwise known as photon radiotherapy, the Sensus SRT system allows for non-invasive treatments…Read More
Superficial Radiation Therapy Strong Alternative to Mohs Surgery for Skin Cancer with Joseph Sardano Sensus Healthcare
Jan 6, 2021
Joseph Sardano, Founder and CEO, Sensus Healthcare presents compelling data on the effectiveness of a non-surgical alternative to Mohs surgery for treating skin cancer and keloids. Using Superficial Radiation Therapy otherwise known as photon radiotherapy, the Sensus SRT system allows for non-invasive treatments…Read More
COVID-19 Therapy Based on AI Pharmaceutical Biotech and Ethnobotanicals with Dr. Saran Saund Oncotelic Therapeutics TRANSCRIPT
Dec 24, 2020
Dr. Saran Saund, Chief Business Officer, Oncotelic Therapeutics is an immuno-oncology company dedicated to developing RNA cancer therapies for melanoma and pancreatic cancer using their nano molecular therapy platform. Using AI they recently screened several of their own molecules and ethnobotanicals for COVID-19. As…Read More
COVID-19 Therapy Based on AI Pharmaceutical Biotech and Ethnobotanicals with Dr. Saran Saund Oncotelic Therapeutics
Dec 23, 2020
Dr. Saran Saund, Chief Business Officer, Oncotelic Therapeutics is an immuno-oncology company dedicated to developing RNA cancer therapies for melanoma and pancreatic cancer using their nano molecular therapy platform. Using AI they recently screened several of their own molecules and ethnobotanicals for COVID-19. As…Read More
Masitinib Targeting and Blocking Mast Cells and Macrophages to Treat COVID-19 with Alain Moussy AB Science TRANSCRIPT
Dec 23, 2020
Alain Moussy, Co-Founder and CEO, AB Science has applied their lead compound Masitinib to target mast cells and macrophage, also known when presenting with CNS as microglia, from the innate immune system to treat Lou Gehrig’s disease, multiple sclerosis, Alzheimer’s disease, tumors, and pancreatic cancer. Now AB…Read More
Masitinib Targeting and Blocking Mast Cells and Macrophages to Treat COVID-19 with Alain Moussy AB Science
Dec 23, 2020
Alain Moussy, Co-Founder and CEO, AB Science has applied their lead compound Masitinib to target mast cells and macrophage, also known when presenting with CNS as microglia, from the innate immune system to treat Lou Gehrig’s disease, multiple sclerosis, Alzheimer’s disease, tumors, and pancreatic cancer. Now AB…Read More
Using AI and Genetic Data in Drug Research to Treat a Rare Neurologic Peripheral Neuropathy with Dr. David Solomon Pharnext TRANSCRIPT
Dec 22, 2020
Dr. David Solomon, CEO, Pharnext is deploying their innovative drug discovery platform that uses genetic data, big data and AI to determine combinations that are novel and non-obvious to find treatments for rare diseases. With a focus on Charcot-Marie-Tooth, a rare neurologic peripheral neuropathy with no current…Read More
Using AI and Genetic Data in Drug Research to Treat a Rare Neurologic Peripheral Neuropathy with Dr. David Solomon Pharnext
Dec 22, 2020
Dr. David Solomon, CEO, Pharnext is deploying their innovative drug discovery platform that uses genetic data, big data and AI to determine combinations that are novel and non-obvious to find treatments for rare diseases. With a focus on Charcot-Marie-Tooth, a rare neurologic peripheral neuropathy with no current…Read More
Developing Effective COVID-19 Oral Vaccine in Tablet Form with Sean Tucker Vaxart TRANSCRIPT
Dec 21, 2020
Sean Tucker, Founder and Chief Scientific Officer, Vaxart is on a mission to expand the choices for a COVID-19 vaccine by producing an effective oral vaccine in tablet form which would allow for more efficient distribution and ease of administering particularly to needle-adverse people. Building on experience developing…Read More
Developing Effective COVID-19 Oral Vaccine in Tablet Form with Sean Tucker Vaxart
Dec 21, 2020
Sean Tucker, Founder and Chief Scientific Officer, Vaxart is on a mission to expand the choices for a COVID-19 vaccine by producing an effective oral vaccine in tablet form which would allow for more efficient distribution and ease of administering particularly to needle-adverse people. Building on experience developing…Read More
COVID-19 Driving Soaring Cyber Crime Attacks on Healthcare Operators with Luke Wilson Constella Intelligence TRANSCRIPT
Dec 16, 2020
Luke Wilson VP Constella Intelligence talks about the digital risk protection space and the increasing attacks on healthcare networks in large part due to opportunities created for cyber criminals by COVID-19. With a lack of awareness about the need for good cyber hygiene and the explosion of new online activities,…Read More
COVID-19 Driving Soaring Cyber Crime Attacks on Healthcare Operators with Luke Wilson Constella Intelligence
Dec 16, 2020
Luke Wilson VP Constella Intelligence talks about the digital risk protection space and the increasing attacks on healthcare networks in large part due to opportunities created for cyber criminals by COVID-19. With a lack of awareness about the need for good cyber hygiene and the explosion of new online activities,…Read More
Preventing Disability from Dupuytren’s Contracture with Dr. Jim Woody 180 Life Sciences TRANSCRIPT
Dec 15, 2020
Dr. Jim Woody, CEO, 180 Life Sciences is one of four world-renowned scientists that have come together to form 180 LS to focus on treating inflammation, fibrosis and pain. Jim discusses the company’s lead clinical program using anti-TNF to treat Dupuytren’s contracture, a fibrotic disease of the hand. With a goal of…Read More
Preventing Disability from Dupuytren’s Contracture with Dr. Jim Woody 180 Life Sciences
Dec 15, 2020
Dr. Jim Woody, CEO, 180 Life Sciences is one of four world-renowned scientists that have come together to form 180 LS to focus on treating inflammation, fibrosis and pain. Jim discusses the company’s lead clinical program using anti-TNF to treat Dupuytren’s contracture, a fibrotic disease of the hand. With a goal of…Read More
Treating Hypoxia and Low Oxygen with Drug Compound Trans-Sodium Crocetinate Derived from Saffron with Dr. Robert Cobuzzi Diffusion Pharmaceuticals TRANSCRIPT
Dec 15, 2020
Dr. Robert Cobuzzi, CEO, Diffusion Pharmaceuticals describes the evolution of the thinking about treating hypoxia and low oxygen conditions caused by a variety of diseases and conditions. With modified crocetin derived from the spice saffron harvested from Crocus sativus, Diffusion has come up with a compound…Read More
Treating Hypoxia and Low Oxygen with Drug Compound Trans-Sodium Crocetinate Derived from Saffron with Dr. Robert Cobuzzi Diffusion Pharmaceuticals
Dec 9, 2020
Dr. Robert Cobuzzi, CEO, Diffusion Pharmaceuticals describes the evolution of the thinking about treating hypoxia and low oxygen conditions caused by a variety of diseases and conditions. With modified crocetin derived from the spice saffron harvested from Crocus sativus, Diffusion has come up with a compound…Read More
Fighting Opioid Overdoses with Drug Warning Labels and Available Naloxone with Dr. Joan Kapusnik-Uner First Databank TRANSCRIPT
Dec 8, 2020
Dr. Joan Kapusnik-Uner, Vice President Clinical Content, First Databank is an expert on drug labeling and is concerned about opioid misuse and overdoses. She talks about the significance of the AMA recommendation that having an opioid reversal medication called Naloxone be available for all patients prescribed opioid…Read More
Fighting Opioid Overdoses with Drug Warning Labels and Available Naloxone with Dr. Joan Kapusnik-Uner First Databank
Dec 8, 2020
Dr. Joan Kapusnik-Uner, Vice President Clinical Content, First Databank is an expert on drug labeling and is concerned about opioid misuse and overdoses. She talks about the significance of the AMA recommendation that having an opioid reversal medication called Naloxone be available for all patients prescribed opioid…Read More
Accurately Predicting Nature of Cardiac Toxicity of a Drug With Bob Hutchens StemBioSys TRANSCRIPT
Dec 7, 2020
Bob Hutchens, President and CEO, StemBioSys talks about their work building a set of tools that are being used around the world by pharmaceutical companies in early-stage drug discovery. CELLvo and CELLvo Matrix Plus are technologies that grow cells from amniotic fluid from natural births and reverse-engineer them into…Read More
Accurately Predicting Nature of Cardiac Toxicity of a Drug With Bob Hutchens StemBioSys
Dec 7, 2020
Bob Hutchens, President and CEO, StemBioSys talks about their work building a set of tools that are being used around the world by pharmaceutical companies in early-stage drug discovery. CELLvo and CELLvo Matrix Plus are technologies that grow cells from amniotic fluid from natural births and reverse-engineer them into…Read More
Initiating End-of-Life Palliative Care Conversations with Patients with Dr. Caroline DeFilippo CareMount Medical TRANSCRIPT
Dec 2, 2020
Dr. Caroline DeFilippo, practicing internist and associate medical director, CareMount Medical addresses the need for healthcare professionals to have end-of-life conversations with patients sooner than later. With tips for practitioners, Caroline addresses the need to see the whole patient not just the body parts and…Read More
Initiating End-of-Life Palliative Care Conversations with Patients with Dr. Caroline DeFilippo CareMount Medical
Dec 2, 2020
Dr. Caroline DeFilippo, practicing internist and associate medical director, CareMount Medical addresses the need for healthcare professionals to have end-of-life conversations with patients sooner than later. With tips for practitioners, Caroline addresses the need to see the whole patient not just the body parts and…Read More
Moving Pharmacies and Healthcare Providers into the Digital World With Cathy Kuhn Updox TRANSCRIPT
Dec 1, 2020
Cathy Kuhn PharmD, Director of Strategy Consulting, Updox has a deep understanding of the communications needs of pharmacists, healthcare providers, and patients and what issues can be addressed by moving from paper to digital. Updox is creating a secure virtual care online environment to encourage the reduction of…Read More
Moving Pharmacies and Healthcare Providers into the Digital World With Cathy Kuhn Updox
Dec 1, 2020
Cathy Kuhn PharmD, Director of Strategy Consulting, Updox has a deep understanding of the communications needs of pharmacists, healthcare providers, and patients and what issues can be addressed by moving from paper to digital. Updox is creating a secure virtual care online environment to encourage the reduction of…Read More
Intratumoral Therapy the Abscopal Effect and Harnessing Cytokine IL-12 in the Treatment Melanoma with Daniel O’Connor OncoSec Immunotherapies TRANSCRIPT
Nov 30, 2020
Daniel O’Connor, CEO, OncoSec Immunotherapies describes their intratumoral therapy where the drug is injected directly into tumors instead of a systemic treatment thereby avoiding toxicities while also seeing tumors shrink that are not being directly treated, the abscopal effect. OncoSec is using electroporation to…Read More
Intratumoral Therapy the Abscopal Effect and Harnessing Cytokine IL-12 in the Treatment Melanoma with Daniel O’Connor OncoSec Immunotherapies
Nov 30, 2020
Daniel O’Connor, CEO, OncoSec Immunotherapies describes their intratumoral therapy where the drug is injected directly into tumors instead of a systemic treatment thereby avoiding toxicities while also seeing tumors shrink that are not being directly treated, the abscopal effect. OncoSec is using electroporation to…Read More
Genomic Information of Breast Cancer Tumors Drives Precision Medicine Treatment With Dr. Bill Audeh Agendia TRANSCRIPT
Nov 25, 2020
Dr. Bill Audeh, medical oncologist and Chief Medical Officer, Agendia left his 30 year career of medical practice treating breast cancer patients to join Agendia because of the exciting opportunities for precision medicine to treat breast cancer. With technology that allows for genomic testing of the cancer tumors, it…Read More
Genomic Information of Breast Cancer Tumors Drives Precision Medicine Treatment With Dr. Bill Audeh Agendia
Nov 25, 2020
Dr. Bill Audeh, medical oncologist and Chief Medical Officer, Agendia left his 30 year career of medical practice treating breast cancer patients to join Agendia because of the exciting opportunities for precision medicine to treat breast cancer. With technology that allows for genomic testing of the cancer tumors, it…Read More
Addressing the Impact of Stressors on the Body with Catherine Rivier Sentia Medical Sciences TRANSCRIPT
Nov 24, 2020
Catherine Rivier, Co-Founder Sentia Medical is an expert on stressors and the impact physical, emotional, and infectious or inflammatory stressors have on the brain and the body. Her research along with her late husband at the Salk Institute in San Diego led to the discovery of the main stress hormone CRF. Sentia is now…Read More
Addressing the Impact of Stressors on the Body with Catherine Rivier Sentia Medical Sciences
Nov 24, 2020
Catherine Rivier, Co-Founder Sentia Medical is an expert on stressors and the impact physical, emotional, and infectious or inflammatory stressors have on the brain and the body. Her research along with her late husband at the Salk Institute in San Diego led to the discovery of the main stress hormone CRF. Sentia is now…Read More
Remote Patient Monitoring Advances Public Health in the Age of COVID-19 with Tara Davis Rimidi TRANSCRIPT
Nov 23, 2020
Tara Davis Director of Community Health, Rimidi has deep expertise in the development and evaluation of public health prevention programs. She explains why it has become exponentially more difficult to ensure minorities, low income, rural and patients living with chronic conditions to receive even basic care they need…Read More
Remote Patient Monitoring Advances Public Health in the Age of COVID-19 with Tara Davis Rimidi
Nov 23, 2020
Tara Davis Director of Community Health, Rimidi has deep expertise in the development and evaluation of public health prevention programs. She explains why it has become exponentially more difficult to ensure minorities, low income, rural and patients living with chronic conditions to receive even basic care they need…Read More
Preventing Lymphedema from Becoming a Chronic Condition with Dr. Sheri Prentiss LIVE Today Foundation and Rick Carreon Impedimed TRANSCRIPT
Nov 18, 2020
Dr. Sheri Prentiss, physician and founder LIVE Today Foundation and Rick Carreon, CEO and President, Impedimed are excited about their partnership to raise awareness about early diagnosis and treatment of lymphedema to prevent it from becoming a chronic condition. The Impedimed device conducts a simple and fast test to…Read More
Preventing Lymphedema from Becoming a Chronic Condition with Dr. Sheri Prentiss LIVE Today Foundation and Rick Carreon Impedimed
Nov 18, 2020
Dr. Sheri Prentiss, physician and founder LIVE Today Foundation and Rick Carreon, CEO and President, Impedimed are excited about their partnership to raise awareness about early diagnosis and treatment of lymphedema to prevent it from becoming a chronic condition. The Impedimed device conducts a simple and fast test to…Read More
Report on HealthTech Innovation Days Paris 2020 with Christian Pierret Former French Minister of Industry TRANSCRIPT
Nov 16, 2020
Christian Pierret, former French Minister of Industry and member of the board of different biotech and MedTech European companies gives a report on the recent in-person and virtual HealthTech Innovation Days held in Paris in October 2020. Now in it’s second year, HTID attracted international participants, global…Read More
Report on HealthTech Innovation Days Paris 2020 with Christian Pierret Former French Minister of Industry
Nov 16, 2020
Christian Pierret, former French Minister of Industry and member of the board of different biotech and MedTech European companies gives a report on the recent in-person and virtual HealthTech Innovation Days held in Paris in October 2020. Now in it’s second year, HTID attracted international participants, global…Read More
Combating Burnout with Gratitude Acceptance Intention and Non-Judgement with Dr. Greg Hammer Stanford Medical Center and Author TRANSCRIPT
Nov 11, 2020
Greg Hammer MD is a pediatric intensive care physician, pediatric anesthesiologist, Stanford University Medical Center professor, student of Buddhism and author of GAIN Without Pain: The Happiness Handbook for Health Care Professionals. Greg talks about the impact of chronic stress and the wide variety of stressors…Read More
Combating Burnout with Gratitude Acceptance Intention and Non-Judgement with Dr. Greg Hammer Stanford Medical Center and Author
Nov 11, 2020
Greg Hammer MD is a pediatric intensive care physician, pediatric anesthesiologist, Stanford University Medical Center professor, student of Buddhism and author of GAIN Without Pain: The Happiness Handbook for Health Care Professionals. Greg talks about the impact of chronic stress and the wide variety of stressors…Read More
Real Time Updates Connect Care Teams Hospitalized Patients and Family with Dr. Kevin de la Roza Vocera Ease TRANSCRIPT
Nov 10, 2020
Dr. Kevin de la Roza is a pediatric cardiac anesthesiologist and entrepreneur who has developed the Vocera Ease app that allows for care team members and family to stay in touch during the hospitalization of a patient. Especially in the time of COVID-19 and changes in access to the waiting room, this app is a valuable…Read More
Real Time Updates Connect Care Teams Hospitalized Patients and Family with Dr. Kevin de la Roza Vocera Ease
Nov 10, 2020
Dr. Kevin de la Roza is a pediatric cardiac anesthesiologist and entrepreneur who has developed the Vocera Ease app that allows for care team members and family to stay in touch during the hospitalization of a patient. Especially in the time of COVID-19 and changes in access to the waiting room, this app is a valuable…Read More
Driving Drug Price Transparency for Doctors and Patients with Cam Deemer DrFirst TRANSCRIPT
Nov 9, 2020
Cam Deemer, President, DrFirst shines light on the world of drug pricing and the lack of cost transparency for both doctors and patients. DrFirst is working with Prime Therapeutics, a PBM primarily focused on BlueCross and BlueShield, to integrate their data and provide drug price transparency to now 90% of covered…Read More
Driving Drug Price Transparency for Doctors and Patients with Cam Deemer DrFirst
Nov 9, 2020
Cam Deemer, President, DrFirst shines light on the world of drug pricing and the lack of cost transparency for both doctors and patients. DrFirst is working with Prime Therapeutics, a PBM primarily focused on BlueCross and BlueShield, to integrate their data and provide drug price transparency to now 90% of covered…Read More
Widowmaker Heart Attack Leads to Inspiration for App to Improve Medical Supply Chain With Matt Shields Healthcare Advocate TRANSCRIPT
Nov 4, 2020
Matt Shields was a healthy, competitive athlete and designer of the world’s largest telescope when he had a widowmaker heart attack. Saved by the implantation of an Abbott XIENCE stent, Matt was able resume his active life in Australia. During his convalescence, Matt realized that his knowledge about component tracking…Read More
Widowmaker Heart Attack Leads to Inspiration for App to Improve Medical Supply Chain With Matt Shields Healthcare Advocate
Nov 4, 2020
Matt Shields was a healthy, competitive athlete and designer of the world’s largest telescope when he had a widowmaker heart attack. Saved by the implantation of an Abbott XIENCE stent, Matt was able resume his active life in Australia. During his convalescence, Matt realized that his knowledge about component tracking…Read More
Improving Performance of Surgeons with Game Changing Light Field Imaging with Gabe Jones Proprio Vision TRANSCRIPT
Nov 3, 2020
Gabe jones, CEO and Co-Founder Proprio Vision is working with a diverse team to bring a robotic surgical navigation system using mixed reality, AI and immersive tech to the medical field to help make super surgeons. Proprio’s technology exponentially improves instrumental accuracy, surgical navigation by creating 3D…Read More
Improving Performance of Surgeons with Game Changing Light Field Imaging with Gabe Jones Proprio Vision
Nov 3, 2020
Gabe jones, CEO and Co-Founder Proprio Vision is working with a diverse team to bring a robotic surgical navigation system using mixed reality, AI and immersive tech to the medical field to help make super surgeons. Proprio’s technology exponentially improves instrumental accuracy, surgical navigation by creating 3D…Read More
Using Laser to Fight Cytokine Storm in COVID-19 Patients With Dr. Scott Sigman OrthoLazer Centers TRANSCRIPT
Nov 2, 2020
Dr. Scott Sigman, orthopedic surgeon and co-founder OrthoLazer Centers has learned how effective the laser can be from his work on acute injuries, chronic inflammatory conditions and around the time of surgery. As a result, he decided to pursue the idea that laser could be used to treat the cytokine storm in patients…Read More
Using Laser to Fight Cytokine Storm in COVID-19 Patients With Dr. Scott Sigman OrthoLazer Centers
Nov 2, 2020
Dr. Scott Sigman, orthopedic surgeon and co-founder OrthoLazer Centers has learned how effective the laser can be from his work on acute injuries, chronic inflammatory conditions and around the time of surgery. As a result, he decided to pursue the idea that laser could be used to treat the cytokine storm in patients…Read More
Optimizing Pharmacy Benefits for Small Employers with Mark Campbell RxBenefits TRANSCRIPT
Oct 28, 2020
Mark Campbell, Vice President, Clinical Solutions RxBenefits on their technology-enabled prescription benefits services being offered to self-funded employer groups who are managing their own benefits. COVID-19 has driven changes in enrollment and demand for services as well changing the number of prescriptions and…Read More
Optimizing Pharmacy Benefits for Small Employers with Mark Campbell RxBenefits
Oct 28, 2020
Mark Campbell, Vice President, Clinical Solutions RxBenefits on their technology-enabled prescription benefits services being offered to self-funded employer groups who are managing their own benefits. COVID-19 has driven changes in enrollment and demand for services as well changing the number of prescriptions and…Read More
Finding Trusted Resources for Treating Addiction with Dr. Nishi Rawat Appriss Health and OpenBeds TRANSCRIPT
Oct 27, 2020
Dr. Nishi Rawat, Senior Vice President, Appriss Health and Co-Founder OpenBeds shines a light on the challenges of finding appropriate substance abuse disorder and mental health treatment especially in light of the additional challenges from COVID-19. Instead of a clinician facing network, development of a consumer…Read More
Finding Trusted Resources for Treating Addiction with Dr. Nishi Rawat Appriss Health and OpenBeds
Oct 27, 2020
Dr. Nishi Rawat, Senior Vice President, Appriss Health and Co-Founder OpenBeds shines a light on the challenges of finding appropriate substance abuse disorder and mental health treatment especially in light of the additional challenges from COVID-19. Instead of a clinician facing network, development of a consumer…Read More
Novel Cancer Therapeutic Targets and Inhibits Nuclear Beta-Catenin in Desmoid Tumor Study with Rahul Aras Iterion Therapeutics TRANSCRIPT
Oct 26, 2020
Rahul Aras, CEO, Iterion Therapeutics, describes their lead product Tegavivint, a potent selective inhibitor of nuclear beta-catenin, a high-value oncology target because of its role in cell proliferation, differentiation, immune evasion and other aspects of cancer development. An early clinical study in patients with…Read More
Novel Cancer Therapeutic Targets and Inhibits Nuclear Beta-Catenin in Desmoid Tumor Study with Rahul Aras Iterion Therapeutics
Oct 26, 2020
Rahul Aras, CEO, Iterion Therapeutics, describes their lead product Tegavivint, a potent selective inhibitor of nuclear beta-catenin, a high-value oncology target because of its role in cell proliferation, differentiation, immune evasion and other aspects of cancer development. An early clinical study in patients with…Read More
Building Strong Relationships for Preventative and Ongoing Primary Care with Ryan McQuaid PlushCare TRANSCRIPT
Oct 22, 2020
Ryan McQuaid, CEO and Co-Founder, PlushCare describes the digital longitudinal primary care platform they have developed to promote strong relationships between doctors and patients. With an eye to moving telehealth to the next level, PlushCare is focusing on improving healthcare intelligence, preventative actions and…Read More
Building Strong Relationships for Preventative and Ongoing Primary Care with Ryan McQuaid PlushCare
Oct 22, 2020
Ryan McQuaid, CEO and Co-Founder, PlushCare describes the digital longitudinal primary care platform they have developed to promote strong relationships between doctors and patients. With an eye to moving telehealth to the next level, PlushCare is focusing on improving healthcare intelligence, preventative actions and…Read More
Using Gene Therapy to Fight Blindness with Bernard Gilly GenSight Biologics TRANSCRIPT
Oct 21, 2020
Bernard Gilly PhD, CEO and Co-Founder, GenSight Biologics talks about the innovative gene therapy treatments GenSight is developing to fight blinding diseases. Bernard sheds light on treating Leber Hereditary Optic Neuropathy (LHON), a mitochondrial rare disease as well as retinitis pigmentosa (RP). Their goal is to…Read More
Using Gene Therapy to Fight Blindness with Bernard Gilly GenSight Biologics
Oct 21, 2020
Bernard Gilly PhD, CEO and Co-Founder, GenSight Biologics talks about the innovative gene therapy treatments GenSight is developing to fight blinding diseases. Bernard sheds light on treating Leber Hereditary Optic Neuropathy (LHON), a mitochondrial rare disease as well as retinitis pigmentosa (RP). Their goal is to…Read More
Needle Free Injection Technology Helps Overcome Needle Phobia with Scott McFarland IntegriMedical TRANSCRIPT
Oct 20, 2020
Scott McFarland, CEO, IntegriMedical has taken on the challenge of needle phobia and safe and secure disposal of sharp objects in clinics and in the field. Needle free technology is allowing healthcare professionals to quickly administer vaccinations with a greener approach allowing regular biohazard disposal. Working…Read More
Needle Free Injection Technology Helps Overcome Needle Phobia with Scott McFarland IntegriMedical
Oct 20, 2020
Scott McFarland, CEO, IntegriMedical has taken on the challenge of needle phobia and safe and secure disposal of sharp objects in clinics and in the field. Needle-free technology is allowing healthcare professionals to quickly administer vaccinations with a greener approach allowing regular biohazard disposal. Working…Read More
End of Life Care in the Time of COVID-19 with Melvie Berkery St. Marie’s Hospice TRANSCRIPT
Oct 19, 2020
Melvie Berkery, Executive Director, St. Marie’s Hospice in Detroit talks about the complexities and issues surrounding End of Life Care particularly when healthcare has been upended due to COVID-19. With a mission to help patients and family members make this transition, Melvie explains their philosophy about providing…Read More
End of Life Care in the Time of COVID-19 with Melvie Berkery St. Marie’s Hospice
Oct 19, 2020
Melvie Berkery, Executive Director, St. Marie’s Hospice in Detroit talks about the complexities and issues surrounding End of Life Care particularly when healthcare has been upended due to COVID-19. With a mission to help patients and family members make this transition, Melvie explains their philosophy about providing…Read More
Acromegaly Community Educates and Improves Lives with Jill Sisco Patient Advocate TRANSCRIPT
Oct 14, 2020
Jill Sisco, President, Acromegaly Community talks about her experience with acromegaly beginning in her early twenties. She reveals how difficult it is to diagnose this condition, available therapies, and advancements in turning injectable medications into oral treatments. As a patient advocate for those who suffer from…Read More
Acromegaly Community Educates and Improves Lives with Jill Sisco Patient Advocate
Oct 14, 2020
Jill Sisco, President, Acromegaly Community talks about her experience with acromegaly beginning in her early twenties. She reveals how difficult it is to diagnose this condition, available therapies, and advancements in turning injectable medications into oral treatments. As a patient advocate for those who suffer from…Read More
Raising Awareness of Childhood Cancers Saves Lives with Dr. John Poothullil TRANSCRIPT
Oct 13, 2020
Dr. John Poothullil, is an expert on diabetes and cancer as well as an author. He talks about his newest book When Your Child Has Cancer and what we have learned about the causes and possible treatments for cancers that strike children. With an eye to improving the immune system of the child, Dr. John reminds us that…Read More
Raising Awareness of Childhood Cancers Saves Lives with Dr. John Poothullil
Oct 13, 2020
Dr. John Poothullil, is an expert on diabetes and cancer as well as an author. He talks about his newest book When Your Child Has Cancer and what we have learned about the causes and possible treatments for cancers that strike children. With an eye to improving the immune system of the child, Dr. John reminds us that…Read More
Medical Simulators Drive Innovation in Healthcare Education with Jim Archetto Gaumard Scientific TRANSCRIPT
Oct 7, 2020
Jim Archetto, Vice President Gaumard Scientific describes the range of simulators available to train healthcare professionals in routine medical procedures as well as rarely seen scenarios. Simulation becomes vital in the education process during these days of COVID-19. Life-like patient simulators are being used to…Read More
Medical Simulators Drive Innovation in Healthcare Education with Jim Archetto Gaumard Scientific
Oct 7, 2020
Jim Archetto, Vice President Gaumard Scientific describes the range of simulators available to train healthcare professionals in routine medical procedures as well as rarely seen scenarios. Simulation becomes vital in the education process during these days of COVID-19. Life-like patient simulators are being used to…Read More
Novel Dual Action Treatment of Acute Cardiovascular Syndrome with Craig Fraser Windtree Therapeutics TRANSCRIPT
Oct 5, 2020
Craig Fraser, CEO and President, Windtree Therapeutics talks about acute heart failure, the number one reason for hospitalization in people over 65 and the fact that there has been little innovation in trying to improve cardiac function. Developing a novel dual action drug called istaroxime, Windtree is addressing both…Read More
Novel Dual Action Treatment of Acute Cardiovascular Syndrome with Craig Fraser Windtree Therapeutics
Oct 5, 2020
Craig Fraser, CEO and President, Windtree Therapeutics talks about acute heart failure, the number one reason for hospitalization in people over 65 and the fact that there has been little innovation in trying to improve cardiac function. Developing a novel dual action drug called istaroxime, Windtree is addressing both…Read More
HealthTech Innovation Days Expanding Reach with Virtual and In-Person Events with Maryvonne Hiance and Christian Policard HealthTech For Care TRANSCRIPT
Sep 30, 2020
Maryvonne Hiance, President, and Christian Policard, Board Member, HealthTech For Care talk about the upcoming HealthTech Innovation Days taking place virtually as well as in-person in Paris. Attendance is expected to dramatically increase over the participation at the first event held last year, in part driven by the…Read More
HealthTech Innovation Days Expanding Reach with Virtual and In-Person Events with Maryvonne Hiance and Christian Policard HealthTech For Care
Sep 30, 2020
Maryvonne Hiance, President, and Christian Policard, Board Member, HealthTech For Care talk about the upcoming HealthTech Innovation Days taking place virtually as well as in-person in Paris. Attendance is expected to dramatically increase over the participation at the first event held last year, in part driven by the…Read More
Applying Advances in Cell Cycle Biology to Inhibit CDK2 and CDK9 to Overcome Resistance to Anti-Cancer Therapies with Spiro Rombotis Cyclacel Pharmaceuticals TRANSCRIPT
Sep 30, 2020
Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company’s…Read More
Applying Advances in Cell Cycle Biology to Inhibit CDK2 and CDK9 to Overcome Resistance to Anti-Cancer Therapies with Spiro Rombotis Cyclacel Pharmaceuticals
Sep 30, 2020
Spiro Rombotis, President and Chief Executive Officer, Cyclacel Pharmaceuticals dives into the insights about cell cycle check point control that have led to the development of fadraciclib, a potent orally and intravenously available inhibitor of CDK2 and CDK9 cancer pathways. Drawing on the vision of the company’s…Read More
Refractory Angina Symptoms Significantly Improved by Medical Device with Fred Colen Neovasc TRANSCRIPT
Sep 23, 2020
Fred Colen, Chief Executive Officer, Neovasc sheds light on the four classes of angina and how the quality of life deteriorates for patients suffering from symptoms. Looking for the fundamental reason for the chronic condition of refractory angina has led Neovasc to address the small blood vessels inside the myocardium,…Read More
Refractory Angina Symptoms Significantly Improved by Medical Device with Fred Colen Neovasc
Sep 23, 2020
Fred Colen, Chief Executive Officer, Neovasc sheds light on the four classes of angina and how the quality of life deteriorates for patients suffering from symptoms. Looking for the fundamental reason for the chronic condition of refractory angina has led Neovasc to address the small blood vessels inside the myocardium,…Read More
Injecting New Retina Cells into the Eye to Treat Age-Related Macular Degeneration with Brian Culley Lineage Cell Therapeutics TRANSCRIPT
Sep 22, 2020
Brian Culley, CEO, Lineage Cell Therapeutics talks about the risk we all face from developing age-related macular degeneration – both wet AMD and dry AMD. While there are treatments for wet AMD, currently there is no interventional approved treatment for dry AMD. Lineage is developing a ground-breaking treatment for dry…Read More
Injecting New Retina Cells into the Eye to Treat Age-Related Macular Degeneration with Brian Culley Lineage Cell Therapeutics
Sep 22, 2020
Brian Culley, CEO, Lineage Cell Therapeutics talks about the risk we all face from developing age-related macular degeneration – both wet AMD and dry AMD. While there are treatments for wet AMD, currently there is no interventional approved treatment for dry AMD. Lineage is developing a ground-breaking treatment for dry…Read More
Driving Innovation in Adherence and Personalized Medication Management with Omri Shor Medisafe TRANSCRIPT
Sep 21, 2020
Omri Shor, CEO and co-founder, Medisafe talks about the different aspects of medication adherence and challenges faced by patients trying to maintain their drug therapy schedules. With an eye towards personalized medicine, Medisafe strives to build bridges and integrate healthcare services for patients to allow them to…Read More
Driving Innovation in Adherence and Personalized Medication Management with Omri Shor Medisafe
Sep 21, 2020
Omri Shor, CEO and co-founder, Medisafe talks about the different aspects of medication adherence and challenges faced by patients trying to maintain their drug therapy schedules. With an eye towards personalized medicine, Medisafe strives to build bridges and integrate healthcare services for patients to allow them to…Read More
Turning Injectable Drugs into Oral Therapy with Raj Kannan Chiasma TRANSCRIPT
Sep 17, 2020
Raj Kannan, CEO, Chiasma is focused on bringing to market oral formulations to patients that face significant challenges with their existing injectable therapies. Targeting those suffering from the rare disease acromegaly, recent approval of MYCAPSSA brings the first and only oral somatostatin analog to a predominantly…Read More
Turning Injectable Drugs into Oral Therapy with Raj Kannan Chiasma
Sep 17, 2020
Raj Kannan, CEO, Chiasma is focused on bringing to market oral formulations to patients that face significant challenges with their existing injectable therapies. Targeting those suffering from the rare disease acromegaly, recent approval of MYCAPSSA brings the first and only oral somatostatin analog to a predominantly…Read More
Addressing Epidemic of Concussions and Advances in Treating Traumatic Brain Injuries with Marcy Rogers SpineMark TRANSCRIPT
Sep 14, 2020
Marcy Rogers, CEO and Founder, SpineMark is targeting traumatic brain injuries suffered by athletes, kids, seniors and those getting a concussion from an accident or engagement in a military action. Marcy points out this problem is often ignored and currently there are no treatments for concussions except rest. …Read More
Addressing Epidemic of Concussions and Advances in Treating Traumatic Brain Injuries with Marcy Rogers SpineMark
Sep 14, 2020
Marcy Rogers, CEO and Founder, SpineMark is targeting traumatic brain injuries suffered by athletes, kids, seniors and those getting a concussion from an accident or engagement in a military action. Marcy points out this problem is often ignored and currently there are no treatments for concussions except rest. …Read More
Diagnosing and Managing Impact of Concussions With Harrison Brown HeadCheck Health TRANSCRIPT
Sep 9, 2020
Harrison Brown Co-Founder and CEO, HeadCheck Health wants to make it easy to better identify, diagnose, manage and clear people who have suffered from a concussion to allow them to resume their regular activities. While sports teams and other organizations have developed a concussion protocol for managing those who…Read More
Diagnosing and Managing Impact of Concussions With Harrison Brown HeadCheck Health
Sep 9, 2020
Harrison Brown Co-Founder and CEO, HeadCheck Health wants to make it easy to better identify, diagnose, manage and clear people who have suffered from a concussion to allow them to resume their regular activities. While sports teams and other organizations have developed a concussion protocol for managing those who…Read More
Using Artificial Intelligence at Point of Care with Dr. Jay Anders Medicomp Systems TRANSCRIPT
Sep 8, 2020
Dr. Jay Anders, Chief Medical Officer, Medicomp Systems addresses how COVID-19 has revealed weaknesses in the US healthcare system and the need to address the challenges from the lack of interoperability and accurate point-of-care information. With an eye to the use of artificial intelligence and remembering that the…Read More
Using Artificial Intelligence at Point of Care with Dr. Jay Anders Medicomp Systems
Sep 8, 2020
Dr. Jay Anders, Chief Medical Officer, Medicomp Systems addresses how COVID-19 has revealed weaknesses in the US healthcare system and the need to address the challenges from the lack of interoperability and accurate point-of-care information. With an eye to the use of artificial intelligence and remembering that the…Read More
Leveraging Childhood Vaccination Recall to Fight Cancer with Chris Bradley Loki Therapeutics TRANSCRIPT
Sep 2, 2020
Chris Bradley, CEO and Co-Founder, Loki Therapeutics talks about a new generation of cancer immune therapy that takes advantage of the body’s ability to fight antigens it already recognizes from a previous childhood vaccination. The delivery mechanism uses an attenuated bacteria listeria monocytogenes that colonizes the…Read More
Leveraging Childhood Vaccination Recall to Fight Cancer with Chris Bradley Loki Therapeutics
Sep 2, 2020
Chris Bradley, CEO and Co-Founder, Loki Therapeutics talks about a new generation of cancer immune therapy that takes advantage of the body’s ability to fight antigens it already recognizes from a previous childhood vaccination. The delivery mechanism uses an attenuated bacteria listeria monocytogenes that colonizes the…Read More
Celebrating World Patient Safety Day with Dr. David Mayer Patient Safety Movement Foundation TRANSCRIPT
Sep 1, 2020
Dr. David Mayer, CEO, Patient Safety Movement Foundation is an advocate for awareness of preventable medical harm in healthcare and steps that need to be taken to keep both patients and healthcare workers safe. With a focus on transparency to allow patients to make informed decisions, Dave emphasizes the need to address…Read More
Celebrating World Patient Safety Day with Dr. David Mayer Patient Safety Movement Foundation
Sep 1, 2020
Dr. David Mayer, CEO, Patient Safety Movement Foundation is an advocate for awareness of preventable medical harm in healthcare and steps that need to be taken to keep both patients and healthcare workers safe. With a focus on transparency to allow patients to make informed decisions, Dave emphasizes the need to address…Read More
Developing Immunotherapeutic Technologies to Combat Infectious Disease and Cancer With Dr. Tim Rodell Aethlon Medical TRANSCRIPT
Aug 31, 2020
Dr. Tim Rodell, Chief Executive Officer, Aethlon Medical brings us up to speed on the work at Aethlon in developing immunotherapeutic technologies using their Hemopurifier to clear a virus as well as exosomes in patients with cancer as blood flows through the nanofibers of the Hemopurifier cartridge. With more recent…Read More
Developing Immunotherapeutic Technologies to Combat Infectious Disease and Cancer With Dr. Tim Rodell Aethlon Medical
Aug 31, 2020
Dr. Tim Rodell, Chief Executive Officer, Aethlon Medical brings us up to speed on the work at Aethlon in developing immunotherapeutic technologies using their Hemopurifier to clear a virus as well as exosomes in patients with cancer as blood flows through the nanofibers of the Hemopurifier cartridge. With more recent…Read More
Driving Biomedical Innovation and Partnerships in Interventional Cardiology with David Hochman Orchestra BioMed TRANSCRIPT
Aug 26, 2020
David Hochman, CEO and Founder, Orchestra BioMed is bringing a partnership model to promote healthcare innovation particularly in the field of drug eluting balloons. Their lead product Virtue Sirolimus Angiofusion Balloon (SAB) is delivering an established therapeutic agent in interventional cardiology during balloon…Read More
Driving Biomedical Innovation and Partnerships in Interventional Cardiology with David Hochman Orchestra BioMed
Aug 26, 2020
David Hochman, CEO and Founder, Orchestra BioMed is bringing a partnership model to promote healthcare innovation particularly in the field of drug eluting balloons. Their lead product Virtue Sirolimus Angiofusion Balloon (SAB) is delivering an established therapeutic agent in interventional cardiology during balloon…Read More
Addressing Genetic Mutation that Leads to Rare Disease of the Immune System with Paula Ragan X4 Pharmaceuticals TRANSCRIPT
Aug 25, 2020
Paula Ragan, CEO and President, X4 Pharmamceuticals is developing innovative approaches to treat patients suffering from rare diseases with an initial focus on WHIM syndrome, a rare disease of the immune system that has a basis in a genetic mutation. X4 is also focused on a rare form of lymphoma called Waldenstrom…Read More
Addressing Genetic Mutation that Leads to Rare Disease of the Immune System with Paula Ragan X4 Pharmaceuticals
Aug 25, 2020
Paula Ragan, CEO and President, X4 Pharmaceuticals is developing innovative approaches to treat patients suffering from rare diseases with an initial focus on WHIM syndrome, a rare disease of the immune system that has a basis in a genetic mutation. X4 is also focused on a rare form of lymphoma called Waldenstrom…Read More
From Treatment of Cancer to Developing Novel Therapeutics for COVID-19 with Amit Kumar Anixa Biosciences TRANSCRIPT
Aug 19, 2020
Amit Kumar is President and CEO, Anixa Biosciences, a Silicon Valley based biopharmaceutical company focused on the prevention and treatment of cancer and now developing novel treatments for COVID-19. Using high performance computing, molecular modeling and virtual testing techniques, Anixa is focusing exclusively on…Read More
From Treatment of Cancer to Developing Novel Therapeutics for COVID-19 with Amit Kumar Anixa Biosciences
Aug 19, 2020
Amit Kumar is President and CEO, Anixa Biosciences, a Silicon Valley based biopharmaceutical company focused on the prevention and treatment of cancer and now developing novel treatments for COVID-19. Using high performance computing, molecular modeling and virtual testing techniques, Anixa is focusing exclusively on…Read More
Extending Life of Human Pancreatic Slices Provides Window into Cell Regeneration in the Pancreas with Dr. Juan Dominguez-Bendala Diabetes Research Institute TRANSCRIPT
Aug 18, 2020
Dr. Juan Dominguez-Bendala is Director of Stem Cell Development of Translational Research and Research Associate Professor of Surgery at the UHealth Diabetes Research Institute, Miami Miller School of Medicine. Juan talks about their recent research on the regeneration of the human pancreas using an innovative approach…Read More
Extending Life of Human Pancreatic Slices Provides Window into Cell Regeneration in the Pancreas with Dr. Juan Dominguez-Bendala Diabetes Research Institute
Aug 18, 2020
Dr. Juan Dominguez-Bendala is Director of Stem Cell Development of Translational Research and Research Associate Professor of Surgery at the UHealth Diabetes Research Institute, Miami Miller School of Medicine. Juan talks about their recent research on the regeneration of the human pancreas using an innovative approach…Read More
Preventing Cytokine Storm and Relevance to Treating COVID-19 with Dr. Cameron Durrant Humanigen TRANSCRIPT
Aug 17, 2020
Dr. Cameron Durrant, Chairman and CEO, Humanigen explains the condition called cytokine storm and how their research into GMCSF, the master switch of the cytokine storm, has led to the development of the drug lenzilumab, LENZ, that neutralizes GMCSF. Adding LENZ to Remdesivir has shown promising results in early…Read More
Preventing Cytokine Storm and Relevance to Treating COVID-19 with Dr. Cameron Durrant Humanigen
Aug 17, 2020
Dr. Cameron Durrant, Chairman and CEO, Humanigen explains the condition called cytokine storm and how their research into GMCSF, the master switch of the cytokine storm, has led to the development of the drug lenzilumab, LENZ, that neutralizes GMCSF. Adding LENZ to Remdesivir has shown promising results in early…Read More
Gene Silencing Driving Drug Development for Rare Diseases with Dietrich Stephan NeuBase Therapeutics TRANSCRIPT
Aug 12, 2020
Dietrich Stephan PhD, CEO, NeuBase Therapeutics discusses the history of research into the genetic basis of all diseases, NeuBase’s PATrOL™ platform allowing for intelligent design of drugs that engage with a malfunctioning gene, and the company’s therapies in development for Huntington’s disease and myotonic…Read More
Gene Silencing Driving Drug Development for Rare Diseases with Dietrich Stephan NeuBase Therapeutics
Aug 12, 2020
Dietrich Stephan PhD, CEO, NeuBase Therapeutics discusses the history of research into the genetic basis of all diseases, NeuBase’s PATrOL™ platform allowing for intelligent design of drugs that engage with a malfunctioning gene, and the company’s therapies in development for Huntington’s disease and myotonic…Read More
Intervening in the Aging Process to Treat Age-Associated Diseases with John Dimos Fountain Therapeutics TRANSCRIPT
Aug 11, 2020
John Dimos, CEO, Fountain Therapeutics describes their approach to the treatment of age-associated diseases and points out that there is a big difference between chronological and biological age. In the search for finding a way to intervene in the aging process, Fountain is taking a hypothesis-free approach and with the…Read More
Intervening in the Aging Process to Treat Age-Associated Diseases with John Dimos Fountain Therapeutics
Aug 11, 2020
John Dimos, CEO, Fountain Therapeutics describes their approach to the treatment of age-associated diseases and points out that there is a big difference between chronological and biological age. In the search for finding a way to intervene in the aging process, Fountain is taking a hypothesis-free approach and with the…Read More
Next Generation Inhaled Therapies for Severe Respiratory Diseases with Anne Whitaker Aerami Therapeutics TRANSCRIPT
Aug 10, 2020
Anne Whitaker, CEO, Aerami Therapeutics talks about imatinib their inhaled treatment for the rare disease pulmonary arterial hypertension which could potentially be the first therapy on the market to actually reverse the disease. First approved as a cancer therapy, imatinib stops the progression of the stiffening and…Read More
Next Generation Inhaled Therapies for Severe Respiratory Diseases with Anne Whitaker Aerami Therapeutics
Aug 10, 2020
Anne Whitaker, CEO, Aerami Therapeutics talks about imatinib their inhaled treatment for the rare disease pulmonary arterial hypertension which could potentially be the first therapy on the market to actually reverse the disease. First approved as a cancer therapy, imatinib stops the progression of the stiffening and…Read More
Using Immunotherapy to Treat Glioblastoma Most Aggressive Brain Cancer with Dr. Apostolos Stathopoulos ERC Immunotherapy TRANSCRIPT
Aug 5, 2020
Apostolos Stathopoulos, CEO, ERC-Belgium talks about using immunotherapy to treat glioblastoma, the most malignant of all gliomas or brain cancers. ERC’s therapy, which stimulates the patient’s immune system to mount an immune response against the tumor cells, has demonstrated a clinically meaningful survival benefit…Read More
Using Immunotherapy to Treat Glioblastoma Most Aggressive Brain Cancer with Dr. Apostolos Stathopoulos ERC Immunotherapy
Aug 5, 2020
Apostolos Stathopoulos, CEO, ERC-Belgium talks about using immunotherapy to treat glioblastoma, the most malignant of all gliomas or brain cancers. ERC’s therapy, which stimulates the patient’s immune system to mount an immune response against the tumor cells, has demonstrated a clinically meaningful survival benefit…Read More
Chronic Heart Failure Drug Development Using Patient-Centric Chip Platform with Ayla Annac InvivoSciences TRANSCRIPT
Aug 4, 2020
Ayla Annac, CEO and Co-Founder, InvivoSciences shines light on the next generation of precision medicine and explains how IVS is personalizing the drug development process with patient-derived and gene-edited human samples. The company’s Novel Heart Tissue on a chip platform NuHeart™ enables rapid identification of…Read More
Chronic Heart Failure Drug Development Using Patient-Centric Chip Platform with Ayla Annac InvivoSciences
Aug 4, 2020
Ayla Annac, CEO and Co-Founder, InvivoSciences shines light on the next generation of precision medicine and explains how IVS is personalizing the drug development process with patient-derived and gene-edited human samples. The company’s Novel Heart Tissue on a chip platform NuHeart™ enables rapid identification of…Read More
Explaining COVID-19 to Kids with Mel Kaspin Blume Author TRANSCRIPT
Jul 29, 2020
Mel Kaspin Blume is a copywriter and storyteller and the author of Screens, Beans and Quarantines, a free downloadable children’s book addressing the questions kids have about the impact of COVID-19. With a six year old daughter and three year old son, Mel decided to make up a story to help parents open up…Read More
Explaining COVID-19 to Kids with Mel Kaspin Blume Author
Jul 29, 2020